Highlighting a pipeline of investment and partnership opportunities, focused on addressing unmet needs in prostate cancer.
Proven Connect’s highly experienced leadership team and Translational Scientific Advisory Committee carry out rigorous due diligence on all companies that are included in our portfolio.
We ensure companies can demonstrate their commercial viability and technical rigour as well as their ability to meet a significant patient need.
Proven Connects wrap-around programme of support, in terms of mentorship, patient and clinical engagement and business advice, is designed to increase investors confidence in a companies ability to succeed.
Proven Connect will source a wide range of companies working in diagnostics, therapeutics and care of patients from our networks with pharma, CRO’s, TTO’s and other research organisations.
Explore opportunities with Proven
Interested in investing?
Current Investment Opportunities
These companies have satisfied our due diligence
Proven Connect is looking for impact investors who are seeking new investment opportunities in healthcare that have the clinical and commercial support of experts working in prostate cancer.
Dr Allan Marchington
Managing Director, Head of Life Sciences, Intermediate Capital Group
Disclaimer for the website
Information about companies on the Proven Connect website are provided for information and discussion purposes only and has not been audited or independently verified and no information herein will form the basis of any contract. Neither Proven Connect nor any of its personnel makes any representation, or gives any warranty, in each case express or implied, as to the fairness, accuracy, reasonableness, completeness, or correctness of this presentation or its contents. To the maximum extent permitted by law, neither Proven Connect nor any of its personnel shall be liable (including for negligence) for any direct, indirect, or consequential loss, damage, cost, or expense arising out of or in connection with any person’s use of or reliance on this presentation.